private:alimentaryhealth-2
|
2600603
|
May 22nd, 2019 12:00AM
|
Alimentary Health Limited
|
449
|
36.00
|
Open
|
Biotechnology
|
May 21st, 2019 09:56PM
|
May 21st, 2019 09:56PM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
Open
|
Probiotics, PrecisionBiotic strains, Pharmabiotic, Healthcare, Alflorex, Alflorex Children's Nutrition Drink, Alflorex Children's Straws, B. infantis 35624
|
Open
|
Building 4400, Cork Airport Business Park
|
Cork
|
Cork
|
IE
|
Cork
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Mar 18th, 2018 12:00AM
|
Alimentary Health Limited
|
289
|
22.00
|
Open
|
Biotechnology
|
Mar 18th, 2018 05:28PM
|
Mar 18th, 2018 05:28PM
|
|
Open
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 17th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland. An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via: - Basic and applied research into novel applications - Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products - Marketing of a range of proprietary brands for the clinical and consumer markets AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition. Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 16th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 15th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 14th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 13th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 12th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 11th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|
private:alimentaryhealth-2
|
2600603
|
Feb 10th, 2018 12:00AM
|
Alimentary Health Limited
|
281
|
20.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core probiotic strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported probiotic healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of probiotics and their actives for inflammatory and infectious conditions, reflecting our expertise in gastroinestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the benefits of probiotics. In fact, two key scientific papers detailing the clinical work of AH’s lead strain Bifidobacterium infantis 35624 in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.
|
|
|
|
|
|
|
|
|
|
Alimentary Health
|
|
Health Care Equipment & Services
|